Chartwell Investment Partners’s Phathom Pharmaceuticals PHAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $396K | Buy |
+21,904
| New | +$396K | 0.01% | 406 |
|
|
2022
Q3 | – | Sell |
-68,236
| Closed | -$576K | – | 430 |
|
|
2022
Q2 | $576K | Buy |
68,236
+37,646
| +123% | +$318K | 0.02% | 391 |
|
|
2022
Q1 | $416K | Buy |
30,590
+8,396
| +38% | +$114K | 0.01% | 406 |
|
|
2021
Q4 | $437K | Sell |
22,194
-395
| -2% | -$7.78K | 0.01% | 416 |
|
|
2021
Q3 | $725K | Hold |
22,589
| – | – | 0.02% | 396 |
|
|
2021
Q2 | $765K | Buy |
+22,589
| New | +$765K | 0.02% | 391 |
|